Inaktiver Wert

Andere Sprachen Bone Medical Limited Australian S.E.

Aktien

AU0000BNEDC4

Schlusskurs Australian S.E. Andere Börsenplätze
- ^AUD	-

21.06.	Botanix Pharmaceuticals will 70 Millionen AU$ über eine institutionelle Platzierung einnehmen	MT
21.05.	BOTANIX PHARMACEUTICALS LIMITED : Evans & Partners bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Botanix Pharmaceuticals to Raise AU$70 Million via Institutional Placement	21.06.
Botanix Pharmaceuticals Secures US FDA Approval for Topical Medication	20.06.
Botanix Pharmaceuticals Submits Last Label Materials for Sofdra FDA Approval	12.06.
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index	18.03.
Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27.02.
US FDA Accepts Resubmission of Botanix Pharmaceuticals' Topical Medication	22.01.
Botanix Pharmaceuticals Completes US FDA Resubmission for Topical Medication; Shares Gain 3%	21.12.
Botanix Pharmaceuticals Completes Human Factors Validation Study for Topical Medication; Shares Rise 3%	14.12.
Botanix Pharmaceuticals Secures US FDA Feedback for Topical Medication	04.12.
Botanix Pharmaceuticals Limited Receives Feedback from FDA	03.12.
Botanix Pharmaceuticals Completes Nearly AU$14 Million Institutional Placement	01.12.
Botanix Pharmaceuticals to Raise AU$13.5 Million in Placement; Shares Fall 3%	27.11.
Acne Vulgaris Pipeline\| Clinical Trials, Key Companies - Novan, Bausch Health AOBiome, Ascletis Pharmaceuticals, AnaptysBio, Botanix Pharmaceuticals	07.11.
Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27.10.23
Botanix Pharmaceuticals Signs Telehealth Deal for Dermatological Product	24.10.23
Botanix Pharmaceuticals Secures Conditional US FDA Clearance for Use of 'Sofra' Trade Name	17.10.23
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX Emerging Companies Index	18.09.23
Botanix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31.08.23
Botanix Pharmaceuticals Promotes COO to CEO	25.08.23
Botanix Pharmaceuticals Limited Appoints Howie Mckibbon as Chief Executive Officer	25.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bone Medical Limited Australian S.E.

Aktien

AU0000BNEDC4

Andere Sprachen

Filter